Clinical Trial Update: The Efficacy of Intravenous Pulse in Attaining Remission in Refractory Juvenile Idiopathic Arthritis [Phase 3]

View source ↗

Summary

Phase 3 clinical trial assessing the efficacy of intravenous pulse therapy to induce remission in refractory juvenile idiopathic arthritis; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Juvenile Idiopathic Arthritis

Snippet

Sponsor: Sohag University | Conditions: Refractory Juvenile Idiopathic Arthritis (Despite 2 DMARDs Still Active) | Phase 3 | Status: RECRUITING